Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 616 AL 630

Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson's disease

Zhang XF, Thompson M, Xu YH.

Lab Invest. 2016 May;96(5):496-507. doi: 10.1038/labinvest.2015.161. Epub 2016 Feb 1.

The role of biomarkers and imaging in Parkinson's disease

Algarni MA, Stoessl AJ.

Expert Rev Neurother. 2016;16(2):187-203. doi: 10.1586/14737175.2016.1135056. Epub 2016 Feb 1.

A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson's disease

Zhao HQ, Li FF, Wang Z, Wang XM, Feng T.

Neurol Sci. 2016 May;37(5):749-54. doi: 10.1007/s10072-016-2485-1. Epub 2016 Feb 1.

Lack of association between IL-10 and IL-18 gene promoter polymorphisms and Parkinson's disease with cognitive impairment in a Chinese population

Liu Z, Guo J, Wang Y, Li K, Kang J, Wei Y, Sun Q, Xu Q, Xu C, Yan X, Tang B.

Sci Rep. 2016 Feb 2;6:19021. doi: 10.1038/srep19021.

Successful treatment of Juvenile parkinsonism with bilateral subthalamic deep brain stimulation in a 14-year-old patient with parkin gene mutation

Genç G, Apaydın H, Gündüz A, Poyraz Ç, Oğuz S, Yağcı S, Canaz H, Aydın S, Gündoğdu-Eken A, Başak AN, Ertan S.

Parkinsonism Relat Disord. 2016 Mar;24:137-8. doi: 10.1016/j.parkreldis.2016.01.018. Epub 2016 Jan 23.

New and emerging medical therapies in Parkinson's disease

Lotia M, Jankovic J.

Expert Opin Pharmacother. 2016;17(7):895-909. doi: 10.1517/14656566.2016.1149163. Epub 2016 Feb 19.

Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson's Disease - Results of a Multicenter Open Trial

Kashihara K, Nomura T, Maeda T, Tsuboi Y, Mishima T, Takigawa H, Nakashima K.

Intern Med. 2016;55(3):231-6. doi: 10.2169/internalmedicine.55.5464. Epub 2016 Feb 1.

Early-onset Parkinson's Disease Associated with Chromosome 22q11.2 Deletion Syndrome

Oki M, Hori S, Asayama S, Wate R, Kaneko S, Kusaka H.

Intern Med. 2016;55(3):303-5. doi: 10.2169/internalmedicine.55.5485. Epub 2016 Feb 1.

Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers

Sayad M, Zouambia M, Chaouch M, Ferrat F, Nebbal M, Bendini M, Lesage S, Brice A, Brahim Errahmani M, Asselah B.

BMC Neurosci. 2016 Feb 1;17:6. doi: 10.1186/s12868-016-0240-4.

Verbal Fluency in Parkinson's Patients with and without Bilateral Deep Brain Stimulation of the Subthalamic Nucleus: A Meta-analysis

Wyman-Chick KA.

J Int Neuropsychol Soc. 2016 Apr;22(4):478-85. doi: 10.1017/S1355617716000035. Epub 2016 Feb 1.

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges

Xiao B, Ng HH, Takahashi R, Tan EK.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):697-702. doi: 10.1136/jnnp-2015-312036. Epub 2016 Feb 1.

A Technological Review of the Instrumented Footwear for Rehabilitation with a Focus on Parkinson's Disease Patients

Maculewicz J, Kofoed LB, Serafin S.

Front Neurol. 2016 Jan 20;7:1. doi: 10.3389/fneur.2016.00001. eCollection 2016.

Freezing of gait associated with a corpus callosum lesion

Dale ML, Mancini M, Curtze C, Horak FB, Fling BW.

J Clin Mov Disord. 2016 Jan 29;3:2. doi: 10.1186/s40734-016-0030-2. eCollection 2016.

(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies

Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H.

Ageing Res Rev. 2016 Sep;30:122-33. doi: 10.1016/j.arr.2016.01.001. Epub 2016 Feb 2.

Risk of Injurious Fall and Hip Fracture up to 26 y before the Diagnosis of Parkinson Disease: Nested Case-Control Studies in a Nationwide Cohort

Nyström H, Nordström A, Nordström P.

PLoS Med. 2016 Feb 2;13(2):e1001954. doi: 10.1371/journal.pmed.1001954. eCollection 2016 Feb.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias